Abstract
Cardiac patches consisting of induced pluripotent stem cell‐derived cardiomyocytes (iPSC‐CMs) show beneficial effects when placed on the infarcted heart and the first human clinical trials have been approved. However, current patches do not replicate myocardial tissue, lacking 3D organization, mechanical properties, cellular maturity, and relevant thickness, and thereby fail to
... read more